Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.
Identifieur interne : 004D19 ( Ncbi/Merge ); précédent : 004D18; suivant : 004D20Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.
Auteurs : G M Shepherd [Norvège] ; E. Tauböll ; S J Bakke ; R. Nyberg-HansenSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1997.
English descriptors
- KwdEn :
- Adrenergic beta-Antagonists (therapeutic use), Anticonvulsants (therapeutic use), Antiparkinson Agents (therapeutic use), Cerebral Hemorrhage (complications), Cerebral Hemorrhage (diagnosis), Clonazepam (therapeutic use), Electric Stimulation, Electrodes, Implanted, Humans, Hypertrophy (complications), Hypertrophy (diagnosis), Levodopa (therapeutic use), Magnetic Resonance Imaging, Male, Mesencephalon, Middle Aged, Nerve Degeneration, Neural Pathways, Olivary Nucleus, Pons, Propranolol (therapeutic use), Thalamus, Tremor (drug therapy), Tremor (etiology).
- MESH :
- chemical , therapeutic use : Adrenergic beta-Antagonists, Anticonvulsants, Antiparkinson Agents, Clonazepam, Levodopa, Propranolol.
- complications : Cerebral Hemorrhage, Hypertrophy.
- diagnosis : Cerebral Hemorrhage, Hypertrophy.
- drug therapy : Tremor.
- etiology : Tremor.
- Electric Stimulation, Electrodes, Implanted, Humans, Magnetic Resonance Imaging, Male, Mesencephalon, Middle Aged, Nerve Degeneration, Neural Pathways, Olivary Nucleus, Pons, Thalamus.
Abstract
A severe rest tremor arose in a patient's right arm 9 months after a pontine tegmental hemorrhage. Magnetic resonance studies at 4 and 10 months showed residual hemosiderin in the pons and increasing hypertrophic olivary degeneration (HOD) affecting primarily the left olive. The tremor was refractory to pharmacotherapy (clonazepam, propranolol, and levodopa), but was reduced after implantation of a thalamic stimulator device. Although pontine hemorrhage is among several common causes of HOD, it has not previously been appreciated as a cause of midbrain ("rubral") tremor. A disynaptic dentatorubroolivary tract associated with tremor and monosynaptic dentatoolivary tract associated with HOD may both be components of the rubroolivocerebellorubral loop implicated in midbrain tremor. Their proximity makes the combination of tremor and HOD after pontine tegmental damage plausible and even likely.
DOI: 10.1002/mds.870120327
PubMed: 9159743
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004663
- to stream PubMed, to step Curation: 004663
- to stream PubMed, to step Checkpoint: 004625
Links to Exploration step
pubmed:9159743Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.</title>
<author><name sortKey="Shepherd, G M" sort="Shepherd, G M" uniqKey="Shepherd G" first="G M" last="Shepherd">G M Shepherd</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, National Hospital, University of Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Neurology, National Hospital, University of Oslo</wicri:regionArea>
<wicri:noRegion>University of Oslo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tauboll, E" sort="Tauboll, E" uniqKey="Tauboll E" first="E" last="Tauböll">E. Tauböll</name>
</author>
<author><name sortKey="Bakke, S J" sort="Bakke, S J" uniqKey="Bakke S" first="S J" last="Bakke">S J Bakke</name>
</author>
<author><name sortKey="Nyberg Hansen, R" sort="Nyberg Hansen, R" uniqKey="Nyberg Hansen R" first="R" last="Nyberg-Hansen">R. Nyberg-Hansen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9159743</idno>
<idno type="pmid">9159743</idno>
<idno type="doi">10.1002/mds.870120327</idno>
<idno type="wicri:Area/PubMed/Corpus">004663</idno>
<idno type="wicri:Area/PubMed/Curation">004663</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004625</idno>
<idno type="wicri:Area/Ncbi/Merge">004D19</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.</title>
<author><name sortKey="Shepherd, G M" sort="Shepherd, G M" uniqKey="Shepherd G" first="G M" last="Shepherd">G M Shepherd</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, National Hospital, University of Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Neurology, National Hospital, University of Oslo</wicri:regionArea>
<wicri:noRegion>University of Oslo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tauboll, E" sort="Tauboll, E" uniqKey="Tauboll E" first="E" last="Tauböll">E. Tauböll</name>
</author>
<author><name sortKey="Bakke, S J" sort="Bakke, S J" uniqKey="Bakke S" first="S J" last="Bakke">S J Bakke</name>
</author>
<author><name sortKey="Nyberg Hansen, R" sort="Nyberg Hansen, R" uniqKey="Nyberg Hansen R" first="R" last="Nyberg-Hansen">R. Nyberg-Hansen</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic beta-Antagonists (therapeutic use)</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cerebral Hemorrhage (complications)</term>
<term>Cerebral Hemorrhage (diagnosis)</term>
<term>Clonazepam (therapeutic use)</term>
<term>Electric Stimulation</term>
<term>Electrodes, Implanted</term>
<term>Humans</term>
<term>Hypertrophy (complications)</term>
<term>Hypertrophy (diagnosis)</term>
<term>Levodopa (therapeutic use)</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Mesencephalon</term>
<term>Middle Aged</term>
<term>Nerve Degeneration</term>
<term>Neural Pathways</term>
<term>Olivary Nucleus</term>
<term>Pons</term>
<term>Propranolol (therapeutic use)</term>
<term>Thalamus</term>
<term>Tremor (drug therapy)</term>
<term>Tremor (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic beta-Antagonists</term>
<term>Anticonvulsants</term>
<term>Antiparkinson Agents</term>
<term>Clonazepam</term>
<term>Levodopa</term>
<term>Propranolol</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Cerebral Hemorrhage</term>
<term>Hypertrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cerebral Hemorrhage</term>
<term>Hypertrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Tremor</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Electric Stimulation</term>
<term>Electrodes, Implanted</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Mesencephalon</term>
<term>Middle Aged</term>
<term>Nerve Degeneration</term>
<term>Neural Pathways</term>
<term>Olivary Nucleus</term>
<term>Pons</term>
<term>Thalamus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A severe rest tremor arose in a patient's right arm 9 months after a pontine tegmental hemorrhage. Magnetic resonance studies at 4 and 10 months showed residual hemosiderin in the pons and increasing hypertrophic olivary degeneration (HOD) affecting primarily the left olive. The tremor was refractory to pharmacotherapy (clonazepam, propranolol, and levodopa), but was reduced after implantation of a thalamic stimulator device. Although pontine hemorrhage is among several common causes of HOD, it has not previously been appreciated as a cause of midbrain ("rubral") tremor. A disynaptic dentatorubroolivary tract associated with tremor and monosynaptic dentatoolivary tract associated with HOD may both be components of the rubroolivocerebellorubral loop implicated in midbrain tremor. Their proximity makes the combination of tremor and HOD after pontine tegmental damage plausible and even likely.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">9159743</PMID>
<DateCreated><Year>1997</Year>
<Month>07</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted><Year>1997</Year>
<Month>07</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>12</Volume>
<Issue>3</Issue>
<PubDate><Year>1997</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.</ArticleTitle>
<Pagination><MedlinePgn>432-7</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A severe rest tremor arose in a patient's right arm 9 months after a pontine tegmental hemorrhage. Magnetic resonance studies at 4 and 10 months showed residual hemosiderin in the pons and increasing hypertrophic olivary degeneration (HOD) affecting primarily the left olive. The tremor was refractory to pharmacotherapy (clonazepam, propranolol, and levodopa), but was reduced after implantation of a thalamic stimulator device. Although pontine hemorrhage is among several common causes of HOD, it has not previously been appreciated as a cause of midbrain ("rubral") tremor. A disynaptic dentatorubroolivary tract associated with tremor and monosynaptic dentatoolivary tract associated with HOD may both be components of the rubroolivocerebellorubral loop implicated in midbrain tremor. Their proximity makes the combination of tremor and HOD after pontine tegmental damage plausible and even likely.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shepherd</LastName>
<ForeName>G M</ForeName>
<Initials>GM</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, National Hospital, University of Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tauböll</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bakke</LastName>
<ForeName>S J</ForeName>
<Initials>SJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nyberg-Hansen</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>5PE9FDE8GB</RegistryNumber>
<NameOfSubstance UI="D002998">Clonazepam</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9Y8NXQ24VQ</RegistryNumber>
<NameOfSubstance UI="D011433">Propranolol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000319">Adrenergic beta-Antagonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002543">Cerebral Hemorrhage</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002998">Clonazepam</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004558">Electric Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004567">Electrodes, Implanted</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006984">Hypertrophy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D008636">Mesencephalon</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D009410">Nerve Degeneration</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009434">Neural Pathways</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D009847">Olivary Nucleus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D011149">Pons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011433">Propranolol</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013788">Thalamus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014202">Tremor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year>
<Month>5</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1997</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1997</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">9159743</ArticleId>
<ArticleId IdType="doi">10.1002/mds.870120327</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Norvège</li>
</country>
</list>
<tree><noCountry><name sortKey="Bakke, S J" sort="Bakke, S J" uniqKey="Bakke S" first="S J" last="Bakke">S J Bakke</name>
<name sortKey="Nyberg Hansen, R" sort="Nyberg Hansen, R" uniqKey="Nyberg Hansen R" first="R" last="Nyberg-Hansen">R. Nyberg-Hansen</name>
<name sortKey="Tauboll, E" sort="Tauboll, E" uniqKey="Tauboll E" first="E" last="Tauböll">E. Tauböll</name>
</noCountry>
<country name="Norvège"><noRegion><name sortKey="Shepherd, G M" sort="Shepherd, G M" uniqKey="Shepherd G" first="G M" last="Shepherd">G M Shepherd</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004D19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:9159743 |texte= Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:9159743" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |